Clinical trial

Iressa v BSC (Best Supportive Care) in First Line NSCLC

NCT00259064

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-09-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2004-09-01Date precision: month

Registry last updated2016-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLCunresolved

Interventions

GefitinibDRUG · verified · RxNorm: gefitinib

PlaceboOTHER

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

TorontoOntario, Canada1 OttawaOntario, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1 AmsterdamNetherlands1 HamiltonOntario, Canada1 WinnipegManitoba, Canada1 HalifaxNova Scotia, Canada1 BirminghamUnited Kingdom1 KingstonOntario, Canada1 LeedsUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00259064 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.